Background and purpose Esophageal cancer is the third most common gastrointestinal
malignancy with a poor long-term survival and high mortality. Surgical resection provides the …

This work highlights the explosion and evolution of positron emission tomography (PET) for
use in oncology research and clinical practice. 2-Deoxy-2-[F-18] fluoro-d-glucose (FDG) …

Background In patients with locally advanced adenocarcinoma of the oesophagogastric
junction (AEG), early metabolic response defined by 18-fluorodeoxyglucose-PET ([18 F] …

Purpose The aim of this study was to evaluate the prognostic value of metabolic tumor
volume (MTV) measured by 18 F-fluorodeoxyglucose positron emission tomography (18 F …

Abstract Purpose 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET)
image-derived parameters, such as standardized uptake value (SUV), functional tumour …

BACKGROUND AND PURPOSE: This prospective study sought to determine how the use of
combined PET/CT for radiotherapy treatment planning of oesophageal cancer would alter …

Purpose To assess the feasibility of combined electromagnetic device tracking and
computed tomography (CT)/ultrasonography (US)/fluorine 18 fluorodeoxyglucose (FDG) …

Purpose This study evaluated prospectively the value of integrated whole-body positron
emission tomography and computed tomography (PET/CT) using [18F] fluorodeoxyglucose …

BACKGROUND: Clinical staging modalities for esophageal cancer are inaccurate at
determining prognosis, especially in early-stage patients. We performed a retrospective …

Abstract Background and Objectives Gastrointestinal specialists generally feel that long
esophageal tumors carry a worse prognosis and are likely to be more advanced than shorter …